Mergers & Acquistions
Project Overview (MBA Course Work): Strategic Acquisition of Mechanix Wear by Fortive
This report outlines the $264.55M acquisition of Mechanix Wear to anchor Fortive’s "Physical Layer" of industrial safety, transforming the company into a full-stack provider of "Intelligent PPE." The strategy leverages the Fortive Business System (FBS) to drive margin expansion while integrating haptic and voltage-sensing technology into premium work gloves. The deal is structured to resolve family governance issues via a 90% cash exit while retaining key leadership through a performance-vesting RSU plan.
Key Performance Metrics
Financial Valuation: $264.55M Enterprise Value
Based on a 10.5x EBITDA multiple, balancing premium brand positioning with disciplined capital allocation.
Strategic Returns: 20% + Target IRR
Optimized through a 20% equity contribution and high-leverage senior debt structure.
Operational Resilience: 1.28x Average DSCR
Maintaining a steady buffer above the 1.25x requirement to ensure debt service under all scenarios.
Strategic Evaluation & Funding Roadmap: Neurotech Spin-out for MGB ($20B Healthcare System)
Strategic Market Assessment: Conducted a comprehensive commercial viability study for a clinical-stage neuro-tech innovation to define its go-to-market strategy and institutional investment readiness.
Evidence-Based Risk Mitigation: Identified significant clinical adoption barriers and financial risks in primary surgical markets through deep-dive competitive benchmarking and interviews with medical directors and anesthesiologists.
Funding & Pivot Roadmap: Developed a strategic pivot toward high-margin, less time-sensitive sectors (such as insurance and pediatrics) and outlined a phased $3M–$5M capital allocation plan to achieve regulatory de-risking.
